바카라사이트 정보 USA to participate in ‘CHPI Americas,’ a leading pharma event held in the U.S.

[by Sung, Jae Jun] 바카라사이트 정보 USA, the U.S. sales arm of 바카라사이트 정보 Group, announced on May 26 that it had participated in the Convention on Pharmaceutical Ingredients Americas (CPHI Americas), held at the Pennsylvania Convention Center in Philadelphia. At the event, the company promoted the group’s drug products and innovative new drug candidate pipelines.

The CHPI Americas attracted thousands of attendees from more than 500 pharmaceutical companies, distributors, and R&D sectors from more than 50 countries worldwide.

바카라사이트 정보 USA showcased the group’s product portfolio focused on drug products and pipelines from 바카라사이트 정보, 바카라사이트 정보lab, and Pangen Biotech.

바카라사이트 정보 USA showcased 바카라사이트 정보’ famous injections and eye drops. 바카라사이트 정보’ recently FDA approved products, 1% and 2% 2mL multi-dose vials for lidocaine hydrochloride injection, received the spotlight at the convention.

바카라사이트 정보 USA introduced Pangen Biotech’s Erythropoietin (EPO) biosimilar, and its contract development and manufacturing organization (CDMO) business provided for biopharmaceuticals. 바카라사이트 정보 USA also highlighted 바카라사이트 정보lab’s proprietary platform technology under development. Also known as HyDIFFUZE™, it leverages recombinant human natural hyaluronidase to convert intravenous (IV) infusion to subcutaneous (SC) injection.

바카라사이트 정보 USA was actively engaged in business discussions and meetings with buyers and distributors from countries including Latin America, Middle East, Asia, and Africa.

CEO of 바카라사이트 정보 USA, Choi Jae-myung said, “We focused on raising the Group’s global presence and promoting brand competitiveness at CPHI Americas. We plan to engage in further discussions with buyers and distributors at the convention for exploring new business cooperation and export opportunities.”